These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26219896)

  • 1. Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.
    Nahm JH; Kim H; Lee H; Cho JY; Choi YR; Yoon YS; Han HS; Park YN
    Tumour Biol; 2016 Jan; 37(1):393-403. PubMed ID: 26219896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
    Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
    Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
    Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN
    J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness.
    Park H; Lee Y; Lee K; Lee H; Yoo JE; Ahn S; Park YN; Kim H
    Pathol Oncol Res; 2021; 27():604600. PubMed ID: 34257565
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.
    Kim H; Park YN
    Dig Dis; 2014; 32(6):778-85. PubMed ID: 25376296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma.
    Kim GJ; Kim H; Park YN
    PLoS One; 2013; 8(9):e75449. PubMed ID: 24086533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma.
    Zhou DS; Wang HB; Zhou ZG; Zhang YJ; Zhong Q; Xu L; Huang YH; Yeung SC; Chen MS; Zeng MS
    Oncotarget; 2015 Sep; 6(27):24163-77. PubMed ID: 26219398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-smooth muscle actin expression is associated with epithelial-mesenchymal transition and stem-like properties in hepatocellular carcinoma.
    Benzoubir N; Mussini C; Lejamtel C; Dos Santos A; Guillaume C; Desterke C; Samuel D; Bréchot C; Bourgeade MF; Guettier C
    PLoS One; 2015; 10(6):e0130559. PubMed ID: 26110787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
    Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis.
    Park H; Lee H; Seo AN; Cho JY; Choi YR; Yoon YS; Han HS; Park YN; Kim H
    J Pathol Transl Med; 2015 Sep; 49(5):373-81. PubMed ID: 26265684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas.
    Govaere O; Komuta M; Berkers J; Spee B; Janssen C; de Luca F; Katoonizadeh A; Wouters J; van Kempen LC; Durnez A; Verslype C; De Kock J; Rogiers V; van Grunsven LA; Topal B; Pirenne J; Vankelecom H; Nevens F; van den Oord J; Pinzani M; Roskams T
    Gut; 2014 Apr; 63(4):674-85. PubMed ID: 23958557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma.
    Kawai T; Yasuchika K; Ishii T; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Mizumoto M; Hatano E; Uemoto S
    Clin Cancer Res; 2015 Jul; 21(13):3081-91. PubMed ID: 25820415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinicopathological and Prognostic Significance of Nrf2 and Keap1 Expression in Hepatocellular Carcinoma.
    Lee K; Kim S; Lee Y; Lee H; Lee Y; Park H; Nahm JH; Ahn S; Yu SJ; Lee K; Kim H
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Associations between interleukin-17A expression and epithelial-mesenchymal transition in patients with hepatocellular carcinoma].
    Xu J; Wang J; Hu Y; Cheng L; Yu H
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):585-90. PubMed ID: 26714598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma.
    Chan AW; Tong JH; Chan SL; Lai PB; To KF
    Histopathology; 2014 Jun; 64(7):935-50. PubMed ID: 24506513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma.
    Kim YJ; Rhee H; Yoo JE; Alves VAF; Kim GJ; Kim HM; Herman P; Chagas A; Kim H; Park YN
    Histopathology; 2017 Aug; 71(2):217-226. PubMed ID: 28326574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas.
    Mebarki S; Désert R; Sulpice L; Sicard M; Desille M; Canal F; Dubois-Pot Schneider H; Bergeat D; Turlin B; Bellaud P; Lavergne E; Le Guével R; Corlu A; Perret C; Coulouarn C; Clément B; Musso O
    Oncotarget; 2016 Jun; 7(26):39026-39043. PubMed ID: 27191501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
    Yamashita T; Forgues M; Wang W; Kim JW; Ye Q; Jia H; Budhu A; Zanetti KA; Chen Y; Qin LX; Tang ZY; Wang XW
    Cancer Res; 2008 Mar; 68(5):1451-61. PubMed ID: 18316609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
    Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
    Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.
    Rhee H; Kim H; Park YN
    Liver Cancer; 2020 Dec; 9(6):663-681. PubMed ID: 33442539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.